Iovance Biotherapeutics, Inc. (IOVA)
10.80
+0.61
(+5.99%)
USD |
NASDAQ |
Sep 24, 16:00
10.86
+0.06
(+0.56%)
After-Hours: 05:49
Iovance Biotherapeutics Gross Profit (Annual) : 54.38M for Dec. 31, 2025
Gross Profit (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Gross Profit (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 54.38M |
| December 31, 2024 | 17.67M |
| December 31, 2023 | -31.94M |
| December 31, 2022 | -21.14M |
| December 31, 2021 | -13.98M |
| December 31, 2020 | -8.712M |
| December 31, 2019 | -8.123M |
| December 31, 2018 | -0.956M |
| December 31, 2017 | -0.952M |
| Date | Value |
|---|---|
| December 31, 2016 | -0.978M |
| December 31, 2015 | -0.999M |
| December 31, 2014 | -0.0882M |
| December 31, 2013 | -0.0071M |
| December 31, 2012 | -0.0062M |
| December 31, 2011 | -0.0027M |
| December 31, 2010 | -0.0586M |
| December 31, 2009 | -0.0013M |
| December 31, 2008 | -0.0013M |
Gross Profit Definition
Annual, Interim and Preliminary Items - Commercial, Other Financial Companies
Gross Profit (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit (Annual) Benchmarks
| Amgen, Inc. | 26.01B |
| AVITA Medical, Inc. | 58.82M |
| Halozyme Therapeutics, Inc. | 1.091B |
| Neurocrine Biosciences, Inc. | 2.808B |
| Editas Medicine, Inc. | 35.24M |